{"analyses":[{"ciLowerLimit":"0.69","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"0.94","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0062","paramType":"Hazard Ratio (HR)","paramValue":"0.81","statisticalMethod":"Log Rank","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"9","upperLimit":"11","value":"9.8"},{"groupId":"OG001","lowerLimit":"10","upperLimit":"12","value":"11.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"410"},{"groupId":"OG001","value":"409"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Chemotherapy alone until disease progression, unacceptable toxicity, or patient refusal","id":"OG000","title":"Chemotherapy"},{"description":"Chemotherapy and Bevacizumab until disease progression, unacceptable toxicity, or patient refusal","id":"OG001","title":"Chemotherapy + Bevacizumab"}],"paramType":"MEDIAN","populationDescription":"Intention to treat","reportingStatus":"POSTED","timeFrame":"within 6.5 years","title":"Overall Survival: Time From Randomization to Death From Any Cause","type":"PRIMARY","unitOfMeasure":"months"}